Determining the first clinically useful bioassay is tricky, as the concept of a bioassay has evolved over time, and early examples were often crude and lacked the rigorous standardization we see today.

However, a strong contender for the earliest clinically useful bioassay is the Wassermann test, developed in 1906 by August von Wassermann. This test, also known as the Wassermann reaction, was a serological test used to detect syphilis, a sexually transmitted infection.

Here's why the Wassermann test is considered a significant early bioassay:

* Clinical Utility: It was the first widely used test to diagnose syphilis, a major public health concern at the time. It allowed for early detection and treatment, improving patient outcomes.

* Innovative Methodology: It involved using a complement fixation reaction, a groundbreaking technique at the time, to detect the presence of antibodies against syphilis in patient blood.

* Impact on Public Health: The Wassermann test revolutionized the management of syphilis and led to significant progress in understanding and treating the disease.

While other bioassays existed before the Wassermann test, they were often less precise, less standardized, and had limited clinical applications. The Wassermann test stands out as a clear example of a bioassay that had a significant and lasting impact on clinical practice.